Skip to Content

'
Eric A. Strom, M.D, F.A.C.R.

Present Title & Affiliation

Primary Appointment

Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Medical Director, Department of Radiation Oncology, Nellie B. Connally Breast Center, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1982 Northwestern University Medical School, Chicago, IL, MD, Honors Program in Medical Education
1978 Northwestern University, Evanston, IL, BS, Honors Program in Medical Education

Postgraduate Training

1/1986-1/1990 Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
1/1983-1/1985 Clinical Residency, Internal Medicine, University of Kentucky Medical Center, Lexington, KY
1/1982-1/1983 Clinical Internship, Internal Medicine, University of Kentucky Medical Center, Lexington, KY

Board Certifications

6/1990 American Board of Radiology
1/1985 American Board of Internal Medicine

Experience/Service

Academic Appointments

Adjunct Associate Professor, School of Health Sciences, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1/2002-9/2006

Honors and Awards

2006-present Fellow, American College of Radiology, American College of Radiology

Selected Publications

Peer-Reviewed Original Research Articles

1. Takiar V, Akay CL, Stauder MC, Tereffe W, Alvarez RH, Hoffman KE, Perkins GH, Strom EA, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. Springer Plus. e-Pub 3/2014.
2. Yang J, Woodward WA, Reed VK, Strom EA, Perkins GH, Tereffe W, Buchhlz TA, Zhang L, Balter P, Court LE, Li XA, Dong L. Statistical modeling approach to quantitative analysis on inter-observer variability in breast contouring. Int J Radiat Oncol Biol Phys. e-Pub 3/2014. PMID: 24613812.
3. Weksberg DC, Allen PK, Hoffman KE, Litton JK, Strom EA, Shah RR, Kuerer HM, Hunt KK, Buchholz TA, Mittendorf EA. Outcomes and predictive factors for salvage therapy after local-regional recurrence following neoadjuvant chemotherapy and breast conserving therapy. Ann Surg Oncol 20(11):3430-7, 10/2013. e-Pub 5/30/2013. PMID: 23720073.
4. Wang X, Zhang X, Li X, Amos RA, Shaitelman SF, Hoffman K, Howell R, Salehpour M, Zhang SX, Sun TL, Smith B, Tereffe W, Perkins GH, Buchholz TA, Strom EA, Woodward WA. Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits? Br J Radiol 86(1029):20130176, 9/2013. e-Pub 5/31/2013. PMCID: PMC3755395.
5. MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman K. Therapeutic radiation dose delivered to the low axilla during whole breast radiotherapy in the prone position: implications for targeting the undissected axilla. Practical Radiation Oncology. e-Pub 6/2013.
6. Takiar V, Strom EA, Baumann DP, Meric-Bernstam F, Alvarez RH, Gonzalez-Angulo AM. Locoregional Interaction of Ixabepilone (Ixempra) After Breast Cancer Radiation. Oncologist 18(3):265-70, 2013. e-Pub 2/12/2013. PMCID: PMC3607521.
7. Skinner HD, Strom EA, Motwani SB, Woodward WA, Green MC, Babiera G, Booser DJ, Meric-Bernstam F, Buchholz TA. Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy. Radiat Oncol 8(1):13, 2013. e-Pub 1/11/2013. PMCID: PMC3552737.
8. Kim MM, Dawood S, Allen P, Sahin AA, Woodward WA, Smith BD, Strom EA, Hunt KK, Meric-Bernstam F, Gonzalez-Angulo AM, Buchholz TA. Hormone receptor status influences the locoregional benefit of Trastuzumab in patients with non-metastatic breast cancer. Cancer 118(20):4936-43, 10/15/2012. e-Pub 4/17/2012. PMID: 22511276.
9. Iyengar P, Strom EA, Zhang YJ, Whitman GJ, Smith BD, Woodward WA, Yu TK, Buchholz TA. The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer. Oncologist 17(11):1402-1408, 9/2012. PMID: 22982581.
10. Pinnix C, Perkins GH, Strom EA, Tereffe W, Woodward W, Oh JL, Arriaga L, Munsell MF, Kelly P, Hoffman KE, Smith BD, Buchholz TA, Yu TK. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinicl trial. Int J Radiat Oncol Biol Phys 83(4):1089-94, 7/15/2012. e-Pub 12/14/2011. PMID: 22172912.
11. Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the MD Anderson prognostic index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol 19(3):901-907, 3/2012. e-Pub 8/2011. PMID: 21861223.
12. Wang X, Pan T, Pinnix C, Zhang SX, Salehpour M, Sun TL, Gladish G, Strom EA, Perkins GH, Tereffe W, Woodward W, Hoffman KE, Buchholz TA, Yu TK. Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 82(2):708-14, 2/1/2012. e-Pub 3/26/2011. PMID: 21444161.
13. Nagar H, Mittendorf EA, Strom EA, Perkins GH, Oh JL, Tereffe W, Woodward WA, Gonzalez-Angulo AM, Hunt KK, Buchholz TA, Yu TK. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically-staged T3N0 breast cancer. Int J Radiat Oncol Biol Phys 81(3):782-7, 11/1/2011. e-Pub 8/30/2011. PMID: 21885207.
14. Wang X, Amos RA, Zhang X, Taddei PJ, Woodward WA, Hoffman KE, Yu TK, Tereffe W, Oh J, Perkins GH, Salehpour M, Zhang SX, Sun TL, Gillin M, Buchholz TA, Strom EA. External beam accelerated partial-breast irradiation (APBI) using multiple proton beam configurations. Int J Radiat Oncol Biol Phys 80(5):1464-72, 8/2011. e-Pub 8/2010. PMID: 20708848.
15. Reddy JP, Levy L, Oh JL, Strom EA, Perkins GH, Buchholz TA, Woodward WA. Long-Term Outcomes in Patients with Isolated Supraclavicular Nodal Recurrence After Mastectomy and Doxorubicin-Based Chemotherapy for Breast Cancer. Int J Radiat Oncol Biol Phys 80(5):1453-7, 8/2011. e-Pub 12/2010. PMID: 21168284.
16. Albert JM, Buzdar AU, Guzman R, Allen PK, Strom EA, Perkins GH, Woodward WA, Hoffman KE, Tereffe W, Hunt KK, Buchholz TA, Oh JL. Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control. Breast Cancer Res Treat 128(2):421-7, 7/2011. e-Pub 5/8/2011. PMID: 21553292.
17. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, Strom EA, Hunt KK, Tucker SL, Buchholz TA. Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer. Cancer 117(8):1595-601, 4/15/2011. e-Pub 11/8/2010. PMID: 21472707.
18. Arun BK, Dhinghra K, Valero V, Kau SW, Broglio K, Booser D, Guerra L, Yin G, Walters R, Sahin A, Ibrahim N, Buzdar AU, Frye D, Sneige N, Strom E, Ross M, Theriault RL, Vadhan-Raj S, Hortobagyi GN. Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results. Oncologist 16(11):1527-34, 2011. e-Pub 10/31/2011. PMID: 22042783.
19. Walker GV, Smith GL, Perkins GH, Oh JL, Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer 116(17):4000-6, 9/1/2010. e-Pub 6/2010. PMID: 20564117.
20. Woodward WA, Truong PT, Yu TK, Tereffe W, Oh J, Perkins G, Strom E, Meric-Bernstam F, Gonzalez-Angulo AM, Speers C, Ragaz J, Buchholz TA. Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival. Breast Cancer Res Treat 123(2):597-605, 9/2010. e-Pub 3/20/2010. PMID: 20306128.
21. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Strom EA, Tereffe W, Woodward WA, Tucker SL, Hunt KK, Hortobagyi GN, Buchholz TA. Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. Int J Radiat Oncol Biol Phys 77(5):1296-1302, 8/1/2010. e-Pub 5/14/2010. PMID: 20472353.
22. Zhang YJ, Oh JL, Whitman GJ, Iyengar P, Yu TK, Tereffe W, Woodward WA, Perkins G, Buchholz TA, Strom EA. Clinically Apparent Internal Mammary Nodal Metastasis in Patients with Advanced Breast Cancer: Incidence and Local Control. Int J Radiat Oncol Biol Phys 77(4):1113-9, 7/2010. e-Pub 12/2009. PMID: 20004535.
23. Greenbaum MP, Strom EA, Allen PK, Perkins GH, Oh JL, Tereffe W, Yu TK, Buchholz TA, Woodward WA. Low locoregional recurrence rates in patients treated after 2000 with doxorubicin based chemotherapy, modified radical mastectomy, and post-mastectomy radiation. Radiother Oncol 95(3):312-6, 6/2010. e-Pub 3/2010. PMID: 20227126.
24. Graesslin O, Abdulkarim BS, Coutant C, Huguet F, Gabos Z, Hsu L, Marpeau O, Uzan S, Pusztai L, Strom EA, Hortobagyi GN, Rouzier R, Ibrahim NK. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer. J Clin Oncol 28(12):2032-7, 4/20/2010. e-Pub 3/22/2010. PMID: 20308667.
25. Alvarez RH, Booser DJ, Cristofanilli M, Sahin AA, Strom EA, Guerra L, Kau SW, Gonzalez-Angulo AM, Hortobagyi GN, Valero V. Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099. Cancer 116(5):1210-1217, 3/1/2010. e-Pub 1/2010. PMID: 20082452.
26. Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA. Breast conserving surgery in older patients with invasive breast cancer; current patterns of treatment across the United States. J Am Coll Surg 209(4):425-433.e2, 10/2009. e-Pub 8/2009. PMID: 19801315.
27. Whitman GJ, Strom EA. Workup and staging of locally advanced breast cancer. Semin Radiat Oncol 19(4):211-221, 10/2009. PMID: 19732685.
28. Reed VK, Woodward WA, Zhang L, Strom EA, Perkins GH, Tereffe W, Oh JL, Yu TK, Bedrosian I, Whitman GJ, Buchholz TA, Dong L. Automatic Segmentation of Whole Breast Using Atlas Approach and Deformable Image Registration. Int J Radiat Oncol Biol Phys 73(5):1493-500, 4/2009. e-Pub 9/2008. PMCID: PMC2729433.
29. Ludwig MS, McNeese MD, Buchholz TA, Perkins GH, Strom EA. The lateral decubitus breast boost: description, rationale and efficacy. Int J Radiat Oncol Biol Phys 76(1). e-Pub 4/2009. PMID: 19394161.
30. Taylor ME, Haffty BG, Rabinovitch R, Arthur DW, Halberg FE, Strom EA, White JR, Cobleigh MA, Edge SB. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast. Int J Radiat Oncol Biol Phys 73(4):997-1002, 3/2009. PMID: 19251087.
31. Beadle BM, Woodward WA, Tucker SL, Outlaw ED, Allen PK, Oh JL, Strom EA, Perkins GH, Tereffe W, Yu TK, Meric-Bernstam F, Litton JK, Buchholz TA. Ten-Year Recurrence Rates in Young Women With Breast Cancer by Locoregional Treatment Approach. Int J Radiat Oncol Biol Phys 73(3):734-44, 3/2009. e-Pub 8/2008. PMID: 18707822.
32. Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, Meric-Bernstam F, Theriault RL, Buchholz TA, Perkins GH. The impact of pregnancy on breast cancer outcomes in women </=35 years. Cancer 115(6):1174-1184, 3/2009. e-Pub 2/2009. PMID: 19204903.
33. Gonzalez-Angulo AM, Walters R, Broglio K, Frye DK, Strom EA, Theriault RL, Booser DJ, Valero V, Buzdar AU, Hortobagyi GN. Using Response to Primary Chemotherapy to Select Postoperative Therapy: Long-Term Results from a Prospective Phase II Trial in Locally Advanced Primary Breast Cancer. Clin Breast Cancer 8(6):516-21, 12/2008. PMID: 19073507.
34. Strom EA, Yu TK, Rabinovitch RA, Haffty BG, Halbert FE, Taylor ME, White JR, Cobleigh MA, Edge SB. American College of Radiology Appropriateness Criteria on Locally Advanced Breast Cancer. ACR Appropriateness Criteria:6-12, 10/2008.
35. Garg AK, Frija EK, Sun TL, Strom EA, Perkins GH, Oh JL, Yu TK, Woodward WA, Tereffe WA, Salehpour M, Buchholz TA. Effects of Variable Placement of Superior Tangential/Supraclavicular Match Line on Dosimetric Coverage of Level III Axilla/Axillary Apex in Patients Treated with Breast and Supraclavicular Radiotherapy. Int J Radiat Oncol Biol Phys 73(2):370-4, 8/2008. PMID: 18676090.
36. White JR, Halberg FE, Rabinovitch R, Green S, Haffty BG, Solin LJ, Strom EA, Taylor ME, Edge SB. American College of Radiology Appropriateness Criteria((R)) on Conservative Surgery and Radiation: Stages I and II Breast Carcinoma. J Am Coll Radiol 5(6):701-13, 6/2008. PMID: 18514949.
37. Reed VK, Cavalcanti JL, Strom EA, Perkins GH, Oh JL, Tereffe W, Yu TK, Yeung H, Whitman GJ, Bedrosian I, Macapinlac HA, Buchholz TA, Woodward WA. Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer. Int J Radiat Oncol Biol Phys 71(2):435-40, 6/2008. PMID: 18164831.
38. Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA. Locoregional Treatment Outcomes After Multimodality Management Of Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys 72(2):474-84, 4/2008. PMID: 18439768.
39. Smith GL, Smith BD, Giordano SH, Shih YC, Woodward WA, Strom EA, Perkins GH, Tereffe W, Yu TK, Buchholz TA. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 112(6):1371-9, 3/2008. PMID: 18213620.
40. Woodward WA, Durand JB, Tucker SL, Strom EA, Perkins GH, Oh J, Arriaga L, Domain D, Buchholz TA. Prospective analysis of carotid artery flow in breast cancer patients treated with supraclavicular irradiation 8 or more years previously: no increase in ipsilateral carotid stenosis after radiation noted. Cancer 112(2):268-73, 1/2008. PMID: 18000801.
41. Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH. Radiation Use and Long-Term Survival in Breast Cancer Patients with T1, T2 Primary Tumors and One to Three Positive Axillary Lymph Nodes. Int J Radiat Oncol Biol Phys 71(4):1022-7, 1/2008. PMID: 18234447.

Last updated: 3/31/2014